Fujifilm begins commissioning phase of new Netherlands-based manufacturing facility
The facility will increase the production capacity of cell culture media products and provide a hub for European and global markets
Having completed construction, Fujifilm Irvine Scientific is now moving into the commissioning phase of its new sustainable manufacturing facility for cell culture media products in Tilburg, the Netherlands.
In line with this milestone, validation of the facility and equipment is also underway in anticipation of full operations starting in late 2021.
The facility will manufacture dry powder media, liquid media, buffers, and water for injection (WFI), initially increasing the company’s production capacity with greater than 320,000 kg/year of dry powder media and more than 470,000 L/year of liquids. The site also has the physical capacity to allow the company to further expand rapidly.
Completion of this third facility, which joins the company’s manufacturing locations in the US and Japan, marks an important step in the company’s long-term strategy to ensure its capacity is in line with worldwide customer demand.
According to the company, the location of the 250,000 sq. ft manufacturing site is in a key European position, offering customers more local supply with increased efficiency, cost-savings in shipping, and a secure supply chain.
Furthermore, the facility employs strategies that adhere to the Fujifilm Sustainability Value Plan 2030, including working towards a CO2-neutral status, using wind energy for the production process, and using sustainable technologies such as membrane bioreactors for wastewater purification.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance